-
1
-
-
34548258255
-
Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: The V-325 Study Group
-
Ajani JA, Moiseyenko VM, Tjulandin S, et al: Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: The V-325 Study Group. J Clin Oncol 25:3205-3209, 2007
-
(2007)
J Clin Oncol
, vol.25
, pp. 3205-3209
-
-
Ajani, J.A.1
Moiseyenko, V.M.2
Tjulandin, S.3
-
2
-
-
34548241326
-
Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: The V-325 Study Group
-
Ajani JA, Moiseyenko VM, Tjulandin S, et al: Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: The V-325 Study Group. J Clin Oncol 25:3210-3216, 2007
-
(2007)
J Clin Oncol
, vol.25
, pp. 3210-3216
-
-
Ajani, J.A.1
Moiseyenko, V.M.2
Tjulandin, S.3
-
3
-
-
33750949065
-
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 Study Group
-
Van Cutsem E, Moiseyenko VM, Tjulandin S, et al: Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 Study Group. J Clin Oncol 24:4991-4997, 2006
-
(2006)
J Clin Oncol
, vol.24
, pp. 4991-4997
-
-
Van Cutsem, E.1
Moiseyenko, V.M.2
Tjulandin, S.3
-
4
-
-
24944465318
-
Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma
-
Ajani JA, Fodor MB, Tjulandin SA, et al: Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma. J Clin Oncol 23:5660-5667, 2005
-
(2005)
J Clin Oncol
, vol.23
, pp. 5660-5667
-
-
Ajani, J.A.1
Fodor, M.B.2
Tjulandin, S.A.3
-
5
-
-
0021929472
-
Action of oral methylprednisolone in terminal cancer patients: A prospective randomized double-blind study
-
Bruera E, Roca E, Cedaro L, et al: Action of oral methylprednisolone in terminal cancer patients: A prospective randomized double-blind study. Cancer Treat Rep 69:751-754, 1985
-
(1985)
Cancer Treat Rep
, vol.69
, pp. 751-754
-
-
Bruera, E.1
Roca, E.2
Cedaro, L.3
-
6
-
-
0024844292
-
Methylprednisolone as palliative therapy for female terminal cancer patients: The Methylprednisolone Female Preterminal Cancer Study Group
-
Popiela T, Lucchi R, Giongo F: Methylprednisolone as palliative therapy for female terminal cancer patients: The Methylprednisolone Female Preterminal Cancer Study Group. Eur J Cancer Clin Oncol 25:1823-1829, 1989
-
(1989)
Eur J Cancer Clin Oncol
, vol.25
, pp. 1823-1829
-
-
Popiela, T.1
Lucchi, R.2
Giongo, F.3
-
7
-
-
34548292026
-
Docetaxel, cisplatin, and fluorouracil in gastric cancer: Does the punishment fit the crime?
-
Ilson DH: Docetaxel, cisplatin, and fluorouracil in gastric cancer: Does the punishment fit the crime? J Clin Oncol 25:3188-3190, 2007
-
(2007)
J Clin Oncol
, vol.25
, pp. 3188-3190
-
-
Ilson, D.H.1
|